Compound as PARP1 inhibitor and pharmaceutical composition comprising the same

TW202629207APending Publication Date: 2026-07-16CHONG KUN DANG CORPORATION

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: TW114129253
Authority / Receiving Office: TW · TW
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2024-08-01
Filing Date: 2025-07-31
Publication Date: 2026-07-16

Application Information

Patent Timeline

01 Aug 2024

Priority

31 Jul 2025

Application

TW114129253

16 Jul 2026

Publication

TW202629207A

IPC: A61K31/541; A61K31/4178; A61K31/4375; A61K31/44; A61K31/497; A61K31/498; A61K31/5355; A61K31/5365; A61P35/00

Inventors: 高武成; 李在英

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to a compound represented by formula 1, a stereoisomer thereof, a pharmaceutically acceptable salt thereof as a PARP1 inhibitor and a pharmaceutical composition including the same, and a method using the same for preventing or treating PARP1 activity-related diseases and a use thereof.

Need to check novelty before this filing date? Find Prior Art